New patent for Sanofi-aventis Us drug SOLIQUA 100/33

Annual Drug Patent Expirations for SOLIQUA+100%2F33 Soliqua 100/33 is a drug marketed by Sanofi-aventis Us and is included in one NDA. It is available from one supplier. There are nineteen… The post New patent for Sanofi-aventis Us drug SOLIQUA 100/33 appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.

Do NOT follow this link or you will be banned from the site!
%d bloggers like this: